Marion Sassier
Centre Hospitalier Universitaire de Caen Normandie(FR)Université de Caen Normandie(FR)
Publications by Year
Research Areas
Pharmacovigilance and Adverse Drug Reactions, Cancer Immunotherapy and Biomarkers, Drug-Induced Adverse Reactions, Chronic Lymphocytic Leukemia Research, Anesthesia and Sedative Agents
Most-Cited Works
- → Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer(2020)560 cited
- → Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis(2021)182 cited
- → Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer(2020)121 cited
- → Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors(2020)89 cited
- → Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database(2020)76 cited
- → Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database(2019)59 cited
- → Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase®(2020)39 cited
- → Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study(2018)36 cited
- → Comparative study of hypoglycaemia induced by opioids. Is it a class effect?(2019)25 cited
- → Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant(2014)25 cited